119 related articles for article (PubMed ID: 2455268)
1. [Mucoviscidosis: what is the cause of bronchitis?].
Bellon G; Gilly R
Pediatrie; 1988; 43(1):5-10. PubMed ID: 2455268
[TBL] [Abstract][Full Text] [Related]
2. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches.
Puchelle E; de Bentzmann S; Zahm JM
Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436
[TBL] [Abstract][Full Text] [Related]
3. Model of mucociliary clearance in cystic fibrosis lungs.
Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
[TBL] [Abstract][Full Text] [Related]
4. The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum.
Lethem MI; James SL; Marriott C
Am Rev Respir Dis; 1990 Nov; 142(5):1053-8. PubMed ID: 2240828
[TBL] [Abstract][Full Text] [Related]
5. [Early bronchial inflammation in cystic fibrosis].
Puchelle E
J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
[TBL] [Abstract][Full Text] [Related]
6. Control of mucus secretion and ion transport in airways.
Nadel JA; Davis B; Phipps RJ
Annu Rev Physiol; 1979; 41():369-81. PubMed ID: 373597
[TBL] [Abstract][Full Text] [Related]
7. MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.
Henke MO; Renner A; Huber RM; Seeds MC; Rubin BK
Am J Respir Cell Mol Biol; 2004 Jul; 31(1):86-91. PubMed ID: 14988081
[TBL] [Abstract][Full Text] [Related]
8. Rheological and transport properties of airway secretions in cystic fibrosis--relationships with the degree of infection and severity of the disease.
Puchelle E; Jacquot J; Beck G; Zahm JM; Galabert C
Eur J Clin Invest; 1985 Dec; 15(6):389-94. PubMed ID: 3938409
[TBL] [Abstract][Full Text] [Related]
9. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy.
Boucher RC
Annu Rev Med; 2007; 58():157-70. PubMed ID: 17217330
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of bacterial bronchitis in cystic fibrosis.
Smith A
Pediatr Infect Dis J; 1997 Jan; 16(1):91-5; discussion 95-6, 123-6. PubMed ID: 9002117
[TBL] [Abstract][Full Text] [Related]
11. Anoctamin 1 dysregulation alters bronchial epithelial repair in cystic fibrosis.
Ruffin M; Voland M; Marie S; Bonora M; Blanchard E; Blouquit-Laye S; Naline E; Puyo P; Le Rouzic P; Guillot L; Corvol H; Clement A; Tabary O
Biochim Biophys Acta; 2013 Dec; 1832(12):2340-51. PubMed ID: 24080196
[TBL] [Abstract][Full Text] [Related]
12. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
Mall MA
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
[TBL] [Abstract][Full Text] [Related]
13. Acidic pH increases airway surface liquid viscosity in cystic fibrosis.
Tang XX; Ostedgaard LS; Hoegger MJ; Moninger TO; Karp PH; McMenimen JD; Choudhury B; Varki A; Stoltz DA; Welsh MJ
J Clin Invest; 2016 Mar; 126(3):879-91. PubMed ID: 26808501
[TBL] [Abstract][Full Text] [Related]
14. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro.
Feng W; Garrett H; Speert DP; King M
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):710-4. PubMed ID: 9517580
[TBL] [Abstract][Full Text] [Related]
15. Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets.
Haq IJ; Gray MA; Garnett JP; Ward C; Brodlie M
Thorax; 2016 Mar; 71(3):284-7. PubMed ID: 26719229
[TBL] [Abstract][Full Text] [Related]
16. Epithelial cell dysfunction in cystic fibrosis: implications for airways disease.
Boat TF; Cheng PW
Acta Paediatr Scand Suppl; 1989; 363():25-9; discussion 29-30. PubMed ID: 2701921
[TBL] [Abstract][Full Text] [Related]
17. Airway epithelial cells--hyperabsorption in CF?
Kunzelmann K; Schreiber R
Int J Biochem Cell Biol; 2012 Aug; 44(8):1232-5. PubMed ID: 22542896
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively?
Tiddens HA; Donaldson SH; Rosenfeld M; Paré PD
Pediatr Pulmonol; 2010 Feb; 45(2):107-17. PubMed ID: 20082341
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
[TBL] [Abstract][Full Text] [Related]
20. [Inflammation, bronchial hyperreactivity and mucoviscidosis].
Derelle J
Rev Pneumol Clin; 1995; 51(3):175-80. PubMed ID: 7569580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
